CA Stock MarketDetailed Quotes
QPT Quest PharmaTech Inc
- 0.040
- 0.0000.00%
15min DelayMarket Closed Nov 25 16:00 ET
6.77MMarket Cap-2352P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.07052wk High0.00%Turnover Ratio169.13MShares0.01552wk Low-0.017EPS TTM5.55MFloat Cap0.462Historical HighLossP/E (Static)138.75MShs Float0.010Historical Low-0.018EPS LYR0.00%Amplitude--Dividend TTM0.29P/B1Lot Size--Div YieldTTM
About Quest PharmaTech Inc Company
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Company Profile
SymbolQPT
Company NameQuest PharmaTech Inc
Founded1996
MarketTSX
Fiscal Year Ends01-31
Address8123 Roper Road NW
CityEdmonton
CountryCAN
Zip CodeT6E 6S4
Phone+1 780 448-1400
Company Executives
- Name
- Position
- Salary
- Dr. Ragupathy Madiyalakan,, PhD
- Chief Executive Officer and Director
- --
- Pierre Vermette
- Chief Financial Officer
- --
- J. Mark Lievonen, C.A.
- Independent Director
- --
- Bradley J. Glass
- Independent Director
- --
- Jeffrey Shon, J.D.
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data